Regeneron Pharmaceuticals Inc (REGN) announced a profit for fourth quarter that Drops, from the same period last year
The company's earnings totaled $844.6 million, or $7.86 per share. This compares with $917.7 million, or $8.06 per share, last year.
Excluding items, Regeneron Pharmaceuticals Inc reported adjusted earnings of $1.248 billion or $11.44 per share for the period.
The company's revenue for the period rose 2.5% to $3.884 billion from $3.789 billion last year.
Regeneron Pharmaceuticals Inc earnings at a glance (GAAP) :
-Earnings: $844.6 Mln. vs. $917.7 Mln. last year.-EPS: $7.86 vs. $8.06 last year.-Revenue: $3.884 Bln vs. $3.789 Bln last year.
For comments and feedback contact: editorial@rttnews.com
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.